What are treatment options for colorectal cancer

Treatment Options for Colorectal Cancer

I'll explain the main treatment approaches for colorectal cancer based on current medical guidelines. The specific treatment plan depends on several factors including the cancer's location (colon vs. rectum), stage, and your overall health.

Surgery: The Foundation of Treatment

Surgery is the primary treatment for most colorectal cancers that haven't spread extensively:

For Colon Cancer:

• Colectomy - removal of the cancerous portion of the colon along with nearby lymph nodes (small bean-shaped organs that filter immune cells). According to NCCN Guidelines, surgeons remove the tumor with "en bloc removal of regional lymph nodes," meaning they take out the cancer and surrounding lymph nodes in one piece to ensure complete removal.

For Rectal Cancer:

• Transabdominal resection - the standard surgical approach removing the rectum and surrounding tissue
• Transanal local excision - for very select early-stage tumors, where cancer is removed through the anus without major abdominal surgery
• Low anterior resection or abdominoperineal resection - depending on how close the tumor is to the anus

Radiation Therapy

Radiation uses high-energy beams to destroy cancer cells. It's used differently for colon versus rectal cancer:

For Rectal Cancer (more common): According to NCCN Guidelines, radiation is often given before surgery for locally advanced rectal cancer (stages T3, T4, or node-positive disease). Two main approaches exist:

1. Long-course chemoradiation - 5-6 weeks of daily radiation combined with chemotherapy (usually capecitabine or infusional 5-FU)
2. Short-course radiation - 5 treatments over one week, followed by either immediate surgery or a waiting period

For Colon Cancer: Radiation is less commonly used but may be considered for tumors that have grown into nearby structures (T4b disease) or when cancer returns locally.

Chemotherapy: Systemic Treatment

Chemotherapy uses drugs to kill cancer cells throughout the body. The NCCN Guidelines recommend different regimens based on your situation:

Common Chemotherapy Combinations:

• FOLFOX - combines 5-fluorouracil (5-FU), leucovorin, and oxaliplatin
• CAPEOX - combines capecitabine (oral chemotherapy) and oxaliplatin
• FOLFIRI - combines 5-FU, leucovorin, and irinotecan

When Chemotherapy is Used:

• Adjuvant therapy - after surgery to eliminate any remaining cancer cells and reduce recurrence risk (typically for stage III disease and some high-risk stage II)
• Neoadjuvant therapy - before surgery to shrink tumors
• For metastatic disease - to control cancer that has spread to other organs

Targeted Therapy

These drugs target specific molecular features of cancer cells. According to NCCN Guidelines, biomarker testing is essential to determine eligibility:

Anti-EGFR Therapies (for RAS wild-type tumors only):

• Cetuximab (Erbitux) or Panitumumab (Vectibix) - block a protein called EGFR that helps cancer cells grow

Anti-VEGF Therapy:

• Bevacizumab (Avastin) - blocks blood vessel formation that tumors need to grow
• Ramucirumab (Cyramza) - another anti-VEGF drug used in later treatment lines

For Specific Mutations:

• BRAF inhibitors - for tumors with BRAF V600E mutations
• HER2-targeted therapy - for HER2-positive colorectal cancers

Immunotherapy

Immunotherapy helps your immune system recognize and attack cancer cells. According to NCCN Guidelines, this is particularly effective for certain colorectal cancers:

Who Benefits: Patients whose tumors show:

• MSI-H (microsatellite instability-high) or dMMR (deficient mismatch repair) - about 15% of colorectal cancers
• TMB-H (tumor mutational burden-high) - tumors with many genetic mutations

Immunotherapy Drugs:

• Pembrolizumab (Keytruda)
• Nivolumab (Opdivo) - sometimes combined with ipilimumab
• Dostarlimab (Jemperli)

The NCCN Guidelines note that for MSI-H/dMMR rectal cancer, immunotherapy may even be used as the primary treatment in some cases, potentially avoiding surgery and radiation entirely.

Treatment by Stage

Early-Stage (Stage I-II):

• Surgery alone may be sufficient for stage I
• Stage II colon cancer may not need chemotherapy unless high-risk features are present
• Stage II-III rectal cancer typically receives radiation ± chemotherapy before or after surgery

Locally Advanced (Stage III):

• Surgery followed by adjuvant chemotherapy (typically FOLFOX or CAPEOX for 3-6 months)
• For rectal cancer: often radiation/chemoradiation before surgery

Metastatic (Stage IV):

• Combination chemotherapy with targeted therapy or immunotherapy (if MSI-H/dMMR)
• In select cases, surgery to remove metastases (especially liver or lung metastases)
• According to NCCN Guidelines, "multidisciplinary team evaluation, including a surgeon experienced in the resection of hepatobiliary or lung metastases" is recommended for potentially resectable metastatic disease

Important Questions to Ask Your Doctor

1. What stage is my cancer, and how does that affect my treatment options?
2. Has my tumor been tested for biomarkers (RAS, BRAF, MSI/MMR, HER2)?
3. Am I a candidate for less invasive surgical approaches?
4. For rectal cancer: Should I have radiation before or after surgery?
5. What are the potential side effects of each treatment option?
6. If my cancer is MSI-H/dMMR, am I eligible for immunotherapy?
7. Would I benefit from evaluation at a specialized center for complex cases?

Sources

This information is based on:

• NCCN (National Comprehensive Cancer Network) Guidelines for Colon Cancer, Version 5.2025
• NCCN Guidelines for Rectal Cancer, Version 4.2025

These guidelines represent the consensus of leading cancer experts and are updated regularly based on the latest research.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions. Your oncologist will determine the most appropriate treatment approach based on your specific cancer characteristics, overall health, and personal preferences.